POLYMERMEDICS LIMITED
Get an alert when POLYMERMEDICS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-08-20 (in 3mo)
Last made up 2025-08-06
Watchouts
None on the register
Cash
£2M
-1.6% vs 2023
Net assets
£7M
-3.1% vs 2023
Employees
67
+1.5% vs 2023
Profit before tax
-£215K
-113.9% vs 2023
Net assets
4-year trend · vs Basic Materials median
Accounts
4-year trend · latest reflected 2024-12-31
| Metric | Trend | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Turnover | — | — | £9,924,107 | £9,393,623 | |
| Operating profit | — | — | £1,303,967 | £509,389 | |
| Profit before tax | — | — | £1,539,228 | -£214,583 | |
| Net profit | — | — | £1,174,456 | -£236,117 | |
| Cash | £585,769 | £902,945 | £1,804,176 | £1,775,793 | |
| Total assets less current liabilities | £1,628,551 | £6,741,695 | £7,921,341 | £7,632,658 | |
| Net assets | £1,696,008 | £6,503,867 | £7,678,323 | £7,442,206 | |
| Equity | £1,696,008 | £6,503,867 | £7,678,323 | £7,442,206 | |
| Average employees | 70 | 71 | 66 | 67 | |
| Wages | — | — | £2,023,704 | £2,170,297 | |
| Directors' remuneration | — | — | £239,348 | £245,229 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-5.3%
£9,924,107 £9,393,623
-
Cash
-1.6%
£1,804,176 £1,775,793
-
Net assets
-3.1%
£7,678,323 £7,442,206
-
Employees
+1.5%
66 67
-
Operating profit
-60.9%
£1,303,967 £509,389
-
Profit before tax
-113.9%
£1,539,228 -£214,583
-
Wages
+7.2%
£2,023,704 £2,170,297
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Operating margin | — | — | 13.1% | 5.4% | |
| Net margin | — | — | 11.8% | -2.5% | |
| Return on capital employed | — | — | 16.5% | 6.7% | |
| Current ratio | — | — | 2.59x | 2.22x | |
| Interest cover | — | — | 289.77x | 12.50x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- POLYMERMEDICS LIMITED 2012-09-10 → present
- POLYMEROPTIX UK LIMITED 2011-03-10 → 2012-09-10
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PKF Francis Clark
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“At the balance sheet date the company had net current assets of £5,847,828 (2023 - £6,463,195). Management have assessed a number of factors in respect of the appropriateness of the going concern assertion, and in particular the current economic climate with regards to inflationary pressures on raw material and energy costs, and uncertainty created through tariff increases in the US. The company is currently in negotiations with its core customer with regards to pricing, and forecasts have been prepared which support the ability of the company to meet its obligations as and when they fall due. Management will continue to monitor these forecasts in light of the uncertain economic environment. After due consideration of these factors the Directors are satisfied that the company will be able to operate within their available facilities and continue as a going concern for the foreseeable future - being a period no less than 12 months from the date of approval of these financial statements.”
Significant events
- “A full impairment of investments of £858,461 has been recognised in the year.”
- “The company continues to engage in research and development to support the products and services that it offers its customers.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| COLLING, John Reginald | Director | 2011-03-10 | Feb 1975 | British |
| SKYBA, Neil Gary | Director | 2017-03-21 | Sep 1976 | British |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| KLEMMAYER, Mateo | Director | 2012-02-01 | 2018-12-03 |
| KOBUS, Andreas | Director | 2011-03-10 | 2012-01-31 |
| POSCHMANN, Matthias | Director | 2018-12-03 | 2019-05-24 |
| YALLOP, David Michael | Director | 2011-03-10 | 2016-11-16 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Felix Markus Otto Loose | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-03-31 | Active |
| Mr Mateo Klemmayer | Individual | Shares 75–100% | 2016-04-06 | Ceased 2019-03-31 |
Filing timeline
Last 20 of 58 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-09-30 | AA | accounts | Accounts with accounts type full | |
| 2025-08-08 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-01-03 | AA | accounts | Accounts with accounts type full | |
| 2024-08-22 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-08-15 | CH01 | officers | Change person director company with change date | |
| 2024-08-13 | CH01 | officers | Change person director company with change date | |
| 2024-01-12 | AA | accounts | Accounts with accounts type small | |
| 2023-08-21 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-01-08 | AA | accounts | Accounts with accounts type small | |
| 2022-08-22 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-02-02 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2022-02-02 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2022-02-01 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2022-02-01 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2022-01-06 | AA | accounts | Accounts with accounts type full | |
| 2021-08-19 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-03-16 | AA | accounts | Accounts with accounts type full | |
| 2020-10-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-01-31 | AA | accounts | Accounts with accounts type full | |
| 2019-08-06 | CS01 | confirmation-statement | Confirmation statement with updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.